Yashiro Masakazu, Matsuoka Tasuku
Masakazu Yashiro, Tasuku Matsuoka, Department of Surgical Oncology, Osaka City University Graduate School of Medicine, Osaka 545-8585, Japan.
World J Gastroenterol. 2016 Feb 28;22(8):2415-23. doi: 10.3748/wjg.v22.i8.2415.
Fibroblast growth factor receptors (FGFRs) regulate a variety of cellular functions, from embryogenesis to adult tissue homeostasis. FGFR signaling also plays significant roles in the proliferation, invasion, and survival of several types of tumor cells. FGFR-induced alterations, including gene amplification, chromosomal translocation, and mutations, have been shown to be associated with the tumor initiation and progression of gastric cancer, especially in diffuse-type cancers. Therefore, the FGFR signaling pathway might be one of the therapeutic targets in gastric cancer. This review aims to provide an overview of the role of FGFR signaling in tumorigenesis, tumor progression, proliferation, and chemoresistance. We also discuss the accumulating evidence that demonstrates the effectiveness of using clinical therapeutic agents to inhibit FGFR signaling for the treatment of gastric cancer.
成纤维细胞生长因子受体（FGFRs）调节多种细胞功能，从胚胎发生到成体组织稳态。FGFR信号传导在几种类型肿瘤细胞的增殖、侵袭和存活中也发挥着重要作用。FGFR诱导的改变，包括基因扩增、染色体易位和突变，已被证明与胃癌的肿瘤发生和进展相关，尤其是在弥漫型癌症中。因此，FGFR信号通路可能是胃癌的治疗靶点之一。本综述旨在概述FGFR信号传导在肿瘤发生、肿瘤进展、增殖和化疗耐药中的作用。我们还讨论了越来越多的证据，这些证据表明使用临床治疗药物抑制FGFR信号传导治疗胃癌的有效性。
